Add another member to the fast-and-furious AI unicorn club: Simile. Just five months after emerging from stealth and announcing a $100 million Series A led by Index Ventures, it has closed a $200 million Series B at a $2 billion valuation, the startup says.
The B round was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures. CVS is also one of Simile’s marquee customers.